Interleukin-15 to Promote Post-ART Control of HIV
Clinical trial NCT07145164 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07145164
- Sponsor
- Michael Peluso, MD
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-19
- Primary completion
- 2027-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.